LeaderPortfolio
Kulkov
Egor Kulkov
Rank #893
RUSSIAHealthcarePharmaceuticals

Egor Kulkov

Net Worth
$4.71B
0% (24h)
Egor Kulkov, a prominent figure in the pharmaceutical industry, has built a substantial fortune through strategic investments and entrepreneurial ventures. Born in 1971, Kulkov's career began with early investments and partnerships that led him to co-found Pharmstandard in 2003. Today, he maintains a significant stake in Pharmstandard, now a leading pharmaceutical firm in Russia. Kulkov's net worth is estimated at $4.7 billion, reflecting his success in the healthcare sector and strategic investments. Beyond Pharmstandard, Kulkov holds shares in other pharmaceutical companies and is a significant shareholder in the British medical technology firm CMR Surgical. His career and achievements have established him as a key player in the global pharmaceutical landscape.

How to read Egor Kulkov's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Egor Kulkov, we anchor the narrative to Pharmaceuticals and Pharmaceuticals, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $4.71B alongside global rank #893, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (RUSSIA) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life

Egor Nikolaevich Kulkov was born on December 7, 1971, in Novosibirsk, Russia. He earned a Master of Science degree from Novosibirsk State University. During his studies, he formed a pivotal partnership with Viktor Kharitonin. In 1993, they co-founded the trading firm “Kreditinform.”

Rise to Success

Kulkov's career saw a pivotal shift in 1999 when he and Viktor Kharitonin acquired the UfaVita plant, marking their initial foray into the pharmaceutical sector. Their significant breakthrough came in 2003 when, alongside Roman Abramovich and others, they established Pharmstandard by consolidating five factories purchased from ICN Pharmaceuticals. By 2008, Kulkov and Kharitonin had bought out their partners, solidifying their control over Pharmstandard.

Key Business Strategies

Kulkov's business acumen is evident in his ability to identify and invest in ventures with substantial growth potential. He holds stakes in Russian pharmaceutical firms OTCPharm, Biocad, and Generium. He is also the largest shareholder of the British medical technology firm CMR Surgical, renowned for its Versius surgical robotic system.

Philanthropy

Beyond his entrepreneurial pursuits, Egor Kulkov is known for his philanthropic activities. He has supported various charitable initiatives in Russia, focusing on education, healthcare, and environmental conservation. His foundation has funded scholarships for disadvantaged youth and has contributed to the restoration of cultural heritage sites across the country.

Career Timeline

2024

Shareholder of CMR Surgical

Largest shareholder of the British medical technology firm CMR Surgical.

2008

Bought out partners in Pharmstandard

Solidified control over Pharmstandard by buying out the partners with Viktor Kharitonin.

2003

Co-founded Pharmstandard

Established Pharmstandard, consolidating factories from ICN Pharmaceuticals.

1999

Acquired UfaVita plant

Ventured into the pharmaceutical sector with the acquisition of the UfaVita plant.

1993

Co-founded Kreditinform

Co-founded the trading firm Kreditinform with Viktor Kharitonin.

Philanthropic Impact

CharityUndisclosed

Charitable Initiatives in Russia

Supports charitable initiatives in Russia focusing on education, healthcare, and environmental conservation.

Key Business Ventures & Holdings

CompanyStakeValue
CMR Surgical
Pharmstandard

Net Worth History

In-Depth Analysis

Early Life

Egor Nikolaevich Kulkov was born on December 7, 1971, in Novosibirsk, Russia. He earned a Master of Science degree from Novosibirsk State University. During his studies, he formed a pivotal partnership with Viktor Kharitonin. In 1993, they co-founded the trading firm “Kreditinform.”

Rise to Success

Kulkov's career saw a pivotal shift in 1999 when he and Viktor Kharitonin acquired the UfaVita plant, marking their initial foray into the pharmaceutical sector. Their significant breakthrough came in 2003 when, alongside Roman Abramovich and others, they established Pharmstandard by consolidating five factories purchased from ICN Pharmaceuticals. By 2008, Kulkov and Kharitonin had bought out their partners, solidifying their control over Pharmstandard.

Key Business Strategies

Kulkov's business acumen is evident in his ability to identify and invest in ventures with substantial growth potential. He holds stakes in Russian pharmaceutical firms OTCPharm, Biocad, and Generium. He is also the largest shareholder of the British medical technology firm CMR Surgical, renowned for its Versius surgical robotic system.

Philanthropy

Beyond his entrepreneurial pursuits, Egor Kulkov is known for his philanthropic activities. He has supported various charitable initiatives in Russia, focusing on education, healthcare, and environmental conservation. His foundation has funded scholarships for disadvantaged youth and has contributed to the restoration of cultural heritage sites across the country.

Data Sources & Methodology

Figures for Egor Kulkov are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.